Mirum to Host Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases ...
Global X's midstream fund delivered $2,531 on a $1,000 investment over five years, while Invesco's solar play returned just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results